The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence
Abstract
Lipodystrophic syndromes associated with mutations in LMNA, encoding A-type lamins, and with HIV antiretroviral treatments share several clinical characteristics. Nuclear alterations and prelamin A accumulation have been reported in fibroblasts from patients with LMNA mutations and adipocytes exposed to protease inhibitors (PI). As genetically altered lamin A maturation also results in premature ageing syndromes with lipodystrophy, we studied prelamin A expression and senescence markers in cultured human fibroblasts bearing six different LMNA mutations or treated with PIs. As compared to control cells, fibroblasts with LMNA mutations or treated with PIs had nuclear shape abnormalities and reduced proliferative activity that worsened with increasing cellular passages. They exhibited prelamin A accumulation, increased oxidative stress, decreased expression of mitochondrial respiratory chain proteins and premature cellular senescence. Inhibition of prelamin A farnesylation prevented cellular senescence and oxidative stress. Adipose tissue samples from patients with LMNA mutations or treated with PIs also showed retention of prelamin A, overexpression of the cell cycle checkpoint inhibitor p16 and altered mitochondrial markers. Thus, both LMNA mutations and PI treatment result in accumulation of farnesylated prelamin A and oxidative stress that trigger premature cellular senescence. These alterations could participate in the pathophysiology of lipodystrophic syndromes and lead to premature ageing complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To our knowledge, no evidence yet exists on whether antiretroviral compounds can induce senescence in adipocytes in vitro, but it has been demonstrated that protease inhibitors and NRTIs can induce p16 and p21 expression in human adipose tissue (Caron et al, 2007, 2008).”
From The struggle of a good friend getting old: cellular senescence in viral responses and therapy (2021) · cites this paper as Caron et al, 2007
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P., et al. (2003) · Nature · doi:10.1038/nature01629 · Cited by 1,990
Lamin a truncation in Hutchinson-Gilford progeria
De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C. L., Munnich, A., Le Merrer, M., et al. (2003) · Science · doi:10.1126/science.1084125 · Cited by 1,346
Goldman, R. D., Shumaker, D. K., Erdos, M. R., Eriksson, M., Goldman, A. E., Gordon, L. B., Gruenbaum, Y., Khuon, S., Mendez, M., Varga, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402943101 · Cited by 1,103
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
Grinspoon, S. K., & Carr, A. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041811 · Cited by 1,073
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046
Brinkman, K., Smeitink, J. A. M., Romijn, J. A., & Reiss, P. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06102-4 · Cited by 863
Genomic instability in laminopathy-based premature aging
Liu, B., Wang, J., Chan, K. M., Tjia, W. M., Deng, W., Guan, X., Huang, J.-D., Li, K. M., Chau, P. Y., Chen, D. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1266 · Cited by 650
Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation
Varela, I., Cadiñanos, J., Pendás, A. M., Gutiérrez-Fernández, A., Folgueras, A. R., Sánchez, L. M., Zhou, Z., Rodríguez, F. J., Stewart, C. L., Vega, J. A., et al. (2005) · Nature · doi:10.1038/nature04019 · Cited by 466
Bergö, M. O., Gavino, B. J., Ross, J., Schmidt, W. K., Hong, C., Kendall, L. V., Mohr, A., Meta, M. D., Genant, H. K., Jiang, Y., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192460799 · Cited by 443
LMNA mutations in atypical Werner's syndrome
Chen, L., Lee, L., Kudlow, B. A., dos Santos, H. G., Sletvold, O., Shafeghati, Y., Botha, E. G., Garg, A., Hanson, N. B., Martin, G. M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14069-x · Cited by 433
Bastard, J., Caron, M., Vidal, H., Jan, V., Auclair, M., Vigouroux, C., Luboinski, J., Laville, M., Maachi, M., Girard, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08094-7 · Cited by 405
Self-citationCapell, B. C., Erdos, M. R., Madigan, J. P., Fiordalisi, J. J., Varga, R., Conneely, K. N., Gordon, L. B., Der, C. J., Cox, A. D., & Collins, F. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506001102 · Cited by 395
A Protein Farnesyltransferase Inhibitor Ameliorates Disease in a Mouse Model of Progeria
Fong, L. G., Frost, D. J., Meta, M. D., Qiao, X., Yang, S. H., Coffinier, C., & Young, S. G. (2006) · Science · doi:10.1126/science.1124875 · Cited by 315
Yang, S. H., Bergö, M. O., Toth, J. I., Qiao, X., Hu, Y., Sandoval, S., Meta, M. D., Bendale, P. M., Gelb, M. H., Young, S. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504641102 · Cited by 311
Caron, M., Auclair, M., Vigouroux, C., Glorian, M., Forest, C. D., & Capeau, J. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1378 · Cited by 308
Self-citationBeckman, K. B., & Ames, B. N. (2000) · Elsevier eBooks · doi:10.1016/b978-044482650-3/50027-4 · Cited by 307
Navarro, C. L., Cadiñanos, J., Sandre‐Giovannoli, A. D., Bernard, R., Courrier, S., Boccaccio, I., Boyer, A., Kleijer, W. J., Wagner, A., Giuliano, F., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi159 · Cited by 299
Toth, J. I., Yang, S. H., Qiao, X., Beigneux, A. P., Gelb, M. H., Moulson, C. L., Miner, J. H., Young, S. G., & Fong, L. G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505767102 · Cited by 292
Accumulation of Short Telomeres in Human Fibroblasts Prior to Replicative Senescence
Martens, U. M., Chavez, E. A., Poon, S. S. S., Schmoor, C., & Lansdorp, P. M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4823 · Cited by 263
Glynn, M. W., & Glover, T. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi326 · Cited by 259
Prelamin A and lamin A appear to be dispensable in the nuclear lamina
Fong, L. G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27125 · Cited by 249
Vigouroux, C., Auclair, M., Dubosclard, E., Pouchelet, M., Capeau, J., Courvalin, J., & Buendia, B. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.24.4459 · Cited by 239
Self-citationAltered pre-lamin A processing is a common mechanism leading to lipodystrophy
Capanni, C., Mattioli, E., Columbaro, M., Lucarelli, E., Parnaik, V. K., Novelli, G., Wehnert, M. S., Cenni, V., Maraldi, N. M., Squarzoni, S., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi158 · Cited by 226
Young, S. G., Fong, L. G., & Michaelis, S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500011-jlr200 · Cited by 218
Fong, L. G., Ng, J. K., Meta, M. D., Coté, N., Yang, S. H., Stewart, C. L., Sullivan, T., Burghardt, A. J., Majumdar, S., Reue, K., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408558102 · Cited by 209
Caux, F. A., Dubosclard, E., Lascols, O., Buendia, B., Chazouillères, O., Cohen, A. A., Courvalin, J., Laroche, L., Capeau, J., Vigouroux, C., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021506 · Cited by 196
Self-citationVigouroux, C., Magré, J., Vantyghem, M., Bourut, C., Lascols, O., Shackleton, S., Lloyd, D. J., Guerci, B., Padova, G., Valensi, P. E., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1958 · Cited by 179
Self-citationCaron, M., Auclair, M., Sterlingot, H., Kornprobst, M., & Capeau, J. (2003) · AIDS · doi:10.1097/00002030-200311210-00005 · Cited by 176
Self-citationNuclear lamins, diseases and aging
Mattout, A., Dechat, T., Adam, S. A., Goldman, R. D., & Gruenbaum, Y. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.03.007 · Cited by 171
Jan, V., Cervera, P., Maachi, M., Baudrimont, M., Kim, M. J., Vidal, H., Girard, P., Levan, P., Rozenbaum, W., Lombès, A., et al. (2004) · Antiviral Therapy · doi:10.1177/135965350400900412 · Cited by 169
Self-citationNoor, M. A., Flint, O. P., Maa, J., & Parker, R. A. (2006) · AIDS · doi:10.1097/01.aids.0000244200.11006.55 · Cited by 155
ALEXEYEV, M. F., LeDoux, S. P., & Wilson, G. L. (2004) · Clinical Science · doi:10.1042/cs20040148 · Cited by 151
Loss of Proliferative Capacity and Induction of Senescence in Oxidatively Stressed Human Fibroblasts
Chen, J., Stoeber, K., Kingsbury, S. R., Ozanne, S. E., Williams, G. H., & Hales, C. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409153200 · Cited by 148
Boguslavsky, R. L., Stewart, C. L., & Worman, H. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi480 · Cited by 146
Comparison of potential markers of farnesyltransferase inhibition.
Adjei, A. A., Davis, J. N., Erlichman, C., Svingen, P. A., & Kaufmann, S. H. (2000) · PubMed · Cited by 119
Caron, M., Auclair, M., Lagathu, C., Lombès, A., Walker, U. A., Kornprobst, M., & Capeau, J. (2004) · AIDS · doi:10.1097/00002030-200411050-00004 · Cited by 107
Self-citationUnderstanding aging: revealing order out of chaos
Dufour, É., & Larsson, N. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.04.020 · Cited by 103
LIPOFUSCIN ACCUMULATION AND AGEING OF FIBROBLASTS
von Zglinicki, T., Nilsson, E., Döcke, W. D., & Brunk, U. T. (2009) · Gerontology · doi:10.1159/000213728 · Cited by 85
Contribution of p16INK4a to replicative senescence of human fibroblasts
Brookes, S., Rowe, J., del Arroyo, A. G., BOND, J. A., & Peters, G. G. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.035 · Cited by 85
The Free Radical Theory of Aging: The Effect of Age on Serum Mercaptan Levels
Harman, D. (1960) · Journal of Gerontology · doi:10.1093/geronj/15.1.38 · Cited by 73
HIV protease inhibitors block adipocyte differentiation independently of lamin A/C
Kudlow, B. A., Jameson, S. A., & Kennedy, B. K. (2005) · AIDS · doi:10.1097/01.aids.0000186827.91408.90 · Cited by 33
Senior, K. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70279-6 · Cited by 13
Flagged first, then by citations
Cited by
Sorted by citations
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Dechat, T., Pfleghaar, K., Sengupta, K., Shimi, T., Shumaker, D. K., Solimando, L., & Goldman, R. D. (2008) · Genes & Development · doi:10.1101/gad.1652708 · Cited by 940
Lipodystrophies: Genetic and Acquired Body Fat Disorders
Garg, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1159 · Cited by 556
“Adipocyte loss in patients with LMNA mutations may be due to disruption of nuclear envelope functionand integrity resulting in premature cell death (63).”
BackgroundMechanics and functional consequences of nuclear deformations
Kalukula, Y., Stephens, A. D., Lammerding, J., & Gabriele, S. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00480-z · Cited by 475
Energetics, epigenetics, mitochondrial genetics
Wallace, D. C., & Fan, W. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.09.006 · Cited by 519
Metadata
- Authors
- Caron, M., Auclair, M., Donadille, B., Béréziat, V, Guerci, B., Laville, M., Narbonne, H., Bodemer, C., Lascols, O., Capeau, J., & Vigouroux, C.
- Affiliations
- Inserm (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Hospices Civils de Lyon (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- Hôpital Necker-Enfants Malades (FR)
- Corresponding author
- Caron, M
- Venue
- Cell Death & Differentiation
- Published
- 2007-07-06
- Volume
- 14
- Issue
- 10
- Pages
- 1759-1767
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W1979927283
- Cited by
- 226
- References
- 45
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 12 · 2021: 33 · 2020: 8 · 2019: 7 · 2018: 7 · 2017: 9 · 2016: 15 · 2015: 9 · 2014: 12 · 2013: 17 · 2012: 10
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Styrelsen för Internationellt Utvecklingssamarbete
- Sidaction
- European Commission
- Institut National de la Santé et de la Recherche Médicale
- Servier
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- lipodystrophy, LMNA mutations, A-type lamins, HIV protease inhibitors, oxidative stress, premature aging, farnesylation, p16, mitochondrial respiratory chain, nuclear abnormalities, fibroblasts, adipose tissue
- MeSH terms
- Adult, Biopsy, Cells, Cultured, Child, Female, Fibroblasts, Humans, Middle Aged, Mitochondria, Mutation, Nuclear Proteins, Protein Precursors, Cellular Senescence, HIV Protease Inhibitors, Reactive Oxygen Species, Oxidative Stress, Indinavir, Nelfinavir, Cyclin-Dependent Kinase Inhibitor p16, Lamin Type A, Cyclin-Dependent Kinase Inhibitor p21, Lipodystrophy, Familial Partial, Cell Nucleus Shape
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review